Literature DB >> 10837681

Microparticle targeting to M cells.

.   

Abstract

M cells are epithelial cells specialized for sampling viruses and bacteria and perform a critical role in immune surveillance in mucosal tissues. The M cell apical surface is modified with less frequent microvilli and a thinner glycocalyx, and the basolateral membrane is invaginated to form an intraepithelial 'pocket' enclosing leukocytes. These alterations facilitate endocytosis and phagocytosis of microorganisms and transport across the epithelium. In certain tissues, M cell apical membranes exhibit distinct receptors which have been identified with monoclonal antibodies and lectins. Pathogenic bacteria and viruses can recognize the M cell surface and exploit its transcellular transport pathway to gain entry into host tissues. M cells sample and transport synthetic microspheres in a manner similar to microorganisms and thus play an essential role in the delivery of vaccines and drugs to mucosal lymphoid tissues. However, the efficiency of sampling orally delivered microparticles by M cells is low. Strategies are being developed to target microparticles to M cell apical surfaces using M cell-selective probes in order to increase sampling efficiency and bioavailability of drugs and vaccines. Such targeting strategies will likely be critical for the development of more effective vaccines and drugs administered by mucosal routes.

Entities:  

Year:  1998        PMID: 10837681     DOI: 10.1016/s0169-409x(98)00043-x

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  12 in total

Review 1.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Rapid transepithelial transport of prions following inhalation.

Authors:  Anthony E Kincaid; Kathryn F Hudson; Matthew W Richey; Jason C Bartz
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

4.  Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluation.

Authors:  Susanne R Youngren; Rohit Mulik; Byoung Jun; Peter R Hoffmann; Kenneth R Morris; Mahavir B Chougule
Journal:  AAPS PharmSciTech       Date:  2013-09       Impact factor: 3.246

5.  Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.

Authors:  Devika R Bhumkar; Hrushikesh M Joshi; Murali Sastry; Varsha B Pokharkar
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.200

6.  In vivo investigation of ceftiofur-loaded gelatin and PLGA microspheres in beagle dogs.

Authors:  Zhihui Hao; Leilei Wang; Kefeng Xiao; Yongda Zhao; Ming Zou; Qidi Zhang; Zhaopeng Ding; Fenfang Yang; Baohan Qu
Journal:  J Mater Sci Mater Med       Date:  2013-01-26       Impact factor: 3.896

7.  Restricted expression of shiga toxin binding sites on mucosal epithelium of mouse distal colon.

Authors:  Yasuyuki Imai; Takashi Fukui; Kohta Kurohane; Daisei Miyamoto; Yasuo Suzuki; Tomoyuki Ishikawa; Yousuke Ono; Masaki Miyake
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

8.  Targeted binding of PLA microparticles with lipid-PEG-tethered ligands.

Authors:  Wynter J Duncanson; Michael A Figa; Kevin Hallock; Samuel Zalipsky; James A Hamilton; Joyce Y Wong
Journal:  Biomaterials       Date:  2007-08-17       Impact factor: 12.479

9.  Preparation of a nanoscale baohuoside I-phospholipid complex and determination of its absorption: in vivo and in vitro evaluations.

Authors:  Xin Jin; Zhen-hai Zhang; E Sun; Qian Qian; Xiao-bin Tan; Xiao-bin Jia
Journal:  Int J Nanomedicine       Date:  2012-09-13

10.  Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy.

Authors:  Susanne C Diesner; Cornelia Bergmayr; Xue-Yan Wang; Denise Heiden; Sarah Exenberger; Franziska Roth-Walter; Philipp Starkl; Davide Ret; Isabella Pali-Schöll; Franz Gabor; Eva Untersmayr
Journal:  Clin Immunol       Date:  2018-03-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.